Miami biotech receives $3.8M grant

A Miami-based biopharmaceutical company researching antidotes for aging-related diseases has received a $3.8 million grant. Longeveron LLC, founded in 2014, will use the new funding from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grant toward developing stem cell therapies for aging frailty, a physiological decline from aging that the company says heightens vulnerability to advers e and serious health conditions in older people. The syndrome affects 10 percent…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news